Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (92)

2024

  1. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Detección y caracterización de defectos del campo visual mediante perimetría Octopus en glaucoma congénito primario

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 91-97

  3. Immune Analysis Using Vitreous Optical Coherence Tomography Imaging in Rats with Steroid-Induced Glaucoma

    Biomedicines, Vol. 12, Núm. 3

  4. Influence of sex on chronic steroid-induced glaucoma: 24-Weeks follow-up study in rats

    Experimental Eye Research, Vol. 238

  5. Prescription trends for preservative free glaucoma medication in a public health system

    European Journal of Ophthalmology, Vol. 34, Núm. 1, pp. 193-203

  6. Primary congenital glaucoma in two siblings with different compound heterozygous CYP1B1 genotypes

    Ophthalmic Genetics

  7. Smart biodegradable hydrogels: Drug-delivery platforms for treatment of chronic ophthalmic diseases affecting the back of the eye

    International Journal of Pharmaceutics, Vol. 649

2023

  1. Long-acting hybrid microemulsion for the simultaneous treatment of glaucoma and ocular surface diseases

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Peripapillary and macular vascular parameters by optical coherence tomography angiography in primary congenital glaucoma

    Eye (Basingstoke), Vol. 37, Núm. 2, pp. 267-273

  3. Progresión en glaucoma. Guía de práctica clínica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 1, pp. 40-57

  4. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

2022

  1. Comment on: Tear Stability With Masks in Dry Eye Disease

    Cornea, Vol. 41, Núm. 4, pp. e7

  2. Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking

    Pharmaceuticals, Vol. 15, Núm. 7

  3. Effects of Corneal Biomechanical Properties on Rebound Tonometry (Icare200) and Applanation Tonometry (Perkins) Readings in Patients with Primary Congenital Glaucoma

    Journal of Glaucoma, Vol. 31, Núm. 3, pp. 183-190

  4. Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres

    Drug Delivery, Vol. 29, Núm. 1, pp. 2357-2374

  5. Tunable degrees of neurodegeneration in rats based on microsphere-induced models of chronic glaucoma

    Scientific Reports, Vol. 12, Núm. 1

  6. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. Agreement between rebound (Icare ic200) and applanation tonometry (Perkins) in patients with primary congenital glaucoma

    Acta Ophthalmologica, Vol. 99, Núm. 6, pp. 663-668

  2. Analysis of parainflammation in chronic glaucoma using vitreous-oct imaging

    Biomedicines, Vol. 9, Núm. 12

  3. Chronic glaucoma using biodegradable microspheres to induce intraocular pressure elevation. Six-month follow-up

    Biomedicines, Vol. 9, Núm. 6